Back to TCRX

BAKER BROS. ADVISORS LP → TCRX

BAKER BROS. ADVISORS LP TCRX Position History

TScan Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$876K
Q3 2026
Peak value
$2.8M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$2.8M
Q1 2026$2.8M
Q2 2026$2.7M
Q3 2026$876K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$876K2.78M——
Q2 2026$2.7M2.78M——
Q1 2026$2.8M2.78M——
Q4 2025$2.8M2.78M——

Other funds holding TCRX

Other BAKER BROS. ADVISORS LP positions

INCY

Incyte Corporation

$3.7B
INCY

Incyte Corporation

$3.5B
BEIGF

BeOne Medicines Ltd.

$3.2B
INCY

Incyte Corporation

$3B
INCY

Incyte Corporation

$2.9B
BEIGF

BeOne Medicines Ltd.

$2.7B
BEIGF

BeOne Medicines Ltd.

$2.6B
BEIGF

BeOne Medicines Ltd.

$2.5B